Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after
allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated …

Corneal and ocular surface diseases (OSDs) carry significant psychosocial and economic
burden worldwide. We set out to review the literature on the application of artificial …

Purpose To validate the international chronic ocular graft-versus-host disease (GVHD)
diagnostic criteria (ICCGVHD) compared to the National Institute of Health diagnostic criteria …

Ocular graft-versus-host disease (GVHD) is a major complication after allogeneic
hematopoietic stem cell transplantation. Ocular GVHD affects recipients' visual function and …

Graft-versus-host disease (GVHD) is an immune-mediated inflammatory disease resulting
from destruction of host tissue by donor immunoreactive cells and occurs in 30% to 70% of …

The purpose of this paper is to review human leukocyte antigen G (HLA-G) in the eye, its
role in immune tolerance, and the potential therapeutic use of AAV gene transfer and …

Purpose The survival rates of patients undergoing allogeneic hematopoietic stem cell
transplantation (HSCT) have improved. However, HSCT can induce significant long-term …

To describe the experience in a recently created ocular graft-versus-host disease unit in a
tertiary hospital and to detail ocular surface features and complications after allogeneic …

Purpose To evaluate the utilization of scleral lenses and prosthetic replacement of the ocular
surface ecosystem devices (SL/PDs) in the management of ocular graft-versus-host disease …

Immune checkpoint inhibitor therapies and allogeneic hematopoietic cell transplant
(alloHCT) represent two distinct modalities that offer a chance for long-term cure in a diverse …